Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
Journal of the American College of Cardiology|March 8, 2008
Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromesChiara Melloni, Eric D Peterson, Anita Y Chen, et al.Therapeutic Drug Monitoring|December 23, 2017
Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in NeonatesJennifer Le, Brenda Poindexter, Janice E Sullivan, et al.American Heart Journal|November 19, 2011
Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal functionChiara Melloni, Stefan K James, Jennifer A White, et al.Journal of Clinical Pharmacology|December 10, 2019
Dosing of Continuous Fentanyl Infusions in Obese Children: A Population Pharmacokinetic AnalysisAnil R Maharaj, Huali Wu, Kanecia O Zimmerman, et al.JACC. Cardiooncology|August 16, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study DesignChiara Melloni, Susan F Slovin, Allan Blemings, et al.The American Journal of Medicine|July 26, 2017
Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE TrialChiara Melloni, Allison Dunning, Christopher B Granger, et al.Circulation|November 15, 2006
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activityChristopher K Dyke, Steven R Steinhubl, Neal S Kleiman, et al.European Journal of Heart Failure|July 18, 2024
Safety and efficacy of aficamten in patients with non-obstructive hypertrophic cardiomyopathy: A 36-week analysis from FOREST-HCMAhmad Masri, Roberto Barriales-Villa, Perry Elliott, et al.American Heart Journal|November 25, 2010
Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trialChiara Melloni, Sunil V Rao, Thomas J Povsic, et al.Clinical and Translational Science|April 24, 2020
Population Pharmacokinetics of Metoclopramide in Infants, Children, and AdolescentsShufan Ge, Susan R Mendley, Jacqueline G Gerhart, et al.Pageof 8